Your browser doesn't support javascript.
loading
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern.
Pollet, Jeroen; Strych, Ulrich; Chen, Wen-Hsiang; Versteeg, Leroy; Keegan, Brian; Zhan, Bin; Wei, Junfei; Liu, Zhuyun; Lee, Jungsoon; Kundu, Rahki; Adhikari, Rakesh; Poveda, Cristina; Jose Villar, Maria; Rani Thimmiraju, Syamala; Lopez, Brianna; Gillespie, Portia M; Ronca, Shannon; Kimata, Jason T; Reers, Martin; Paradkar, Vikram; Hotez, Peter J; Elena Bottazzi, Maria.
Afiliación
  • Pollet J; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA; Department of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Strych U; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA; Department of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Chen WH; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA; Department of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Versteeg L; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA.
  • Keegan B; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA.
  • Zhan B; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA; Department of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Wei J; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA.
  • Liu Z; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA.
  • Lee J; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA.
  • Kundu R; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA.
  • Adhikari R; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA.
  • Poveda C; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA.
  • Jose Villar M; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA.
  • Rani Thimmiraju S; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA.
  • Lopez B; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
  • Gillespie PM; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA.
  • Ronca S; Department of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Kimata JT; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
  • Reers M; Biological E, Limited, Hyderabad, India.
  • Paradkar V; Biological E, Limited, Hyderabad, India.
  • Hotez PJ; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA; Department of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Department of Biology, Baylor University, Waco, TX, USA; James A. Baker
  • Elena Bottazzi M; Texas Children's Hospital Center for Vaccine Development, Houston, TX, USA; Department of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Department of Biology, Baylor University, Waco, TX, USA. Electronic addr
Vaccine ; 40(26): 3655-3663, 2022 06 09.
Article en En | MEDLINE | ID: mdl-35568591

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article